STAT5A and ductal breast carcinoma in situ: The recruitment of this enzyme by STAT5a in DCIS would be consistent with previous studies demonstrating that siRNA and overexpression of MMP-9 modulate invasion, motility and alterations of cytoskeletal components [48].